Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis

AimTo assess the impact of the HbA1c levels achieved with antidiabetic therapies (ADTs) on the risk of MACE.MethodsA systematic search was performed in PubMed, Cochrane, and ClinicalTrials. gov for RCTs published up to March 2022 reporting the occurrence of MACE and all-cause mortality in individual...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Luiz Sergio Fernandes de Carvalho, Ana Claudia Cavalcante Nogueira, Isabella Bonilha, Beatriz Luchiari, Alexander Benchimol, Carlos Eduardo Barra Couri, Jairo Lins Borges, Joaquim Barreto, Andrei C. Sposito
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2022-04-01
Colecção:Frontiers in Cardiovascular Medicine
Assuntos:
new antidiabetic drugs
MACE
HbA1c
diabetes mellitus
meta-analysis
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fcvm.2022.876795/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados